期刊文献+

核因子κB受体活化因子在破骨细胞培养中表达时相的研究

Time-course expression of receptor activator of nuclear factor κB in osteoclasts culture
下载PDF
导出
摘要 目的本研究旨在观察核因子κB受体活化因子(receptor activator of nuclear factorκB,RANK)在破骨细胞培养中的表达时相。方法采用巨噬细胞集落刺激因子(macrophages colony-stimulating factor,M-CSF)及核因子κB受体活化因子配体(receptor activator of NF-κB ligand,RANKL)作为分化诱导因子,诱导大鼠骨髓造血干细胞分化为破骨细胞,RT-PCR检测诱导分化不同时间点(0,3,5,7 d)破骨细胞膜表面RANK mRNA的表达水平。结果 RT-PCR检测结果显示RANK mRNA表达在培养0 d为1.20±0.47,3 d为1.52±0.58,5 d为1.59±0.57,7 d为1.69±0.51。诱导分化后表达量随培养时间延长而增加,各时间点与培养前比较均有统计学差异(P<0.05)。结论在破骨细胞分化的各个时间段RANK均有表达,是体外研究不同因素影响破骨细胞分化及活化的一个特异性指标。 Objective To explore the time-course expression of receptor activator of nuclear factor κB(RANK) in osteoclast culture.Methods Using macrophages colony-stimulating factor(M-CSF) and receptor activator of NF-κB ligand(RANKL) as inducible factors,bone marrow hematopoietic stem cells from rats were induced to differentiate into the osteoclasts.RT-PCR was used to detect RANK mRNA expression in the osteoclast cell surface at different culture time points(0 d,3 d,5 d,7 d).Results RT-PCR resucts showed RANK mRNA expression increased in a time-dependent manner,and was significantly higher at day 3-7 than that at day 0 [1.52±0.58 at day 3,1.59±0.57 at day 5 and 1.69±0.51 at day 7 vs 1.20±0.47 at day 0,P0.05].Conclusion RANK expresses at different time points of osteoclast differentiation.It is a specific indicator for in vitro studies on different influential factors of osteoclast differentiation and activation.
出处 《山西医科大学学报》 CAS 2011年第9期735-737,776,共4页 Journal of Shanxi Medical University
关键词 核因子ΚB受体活化因子 破骨细胞 分化 receptor activator of nuclear factor κB osteoclast differentiation
  • 相关文献

参考文献9

  • 1Takahashi N,Udagawa N,Tanaka S,et al.Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes[J].Dev Biol,1994,163:212-221.
  • 2Teitelbaum SL.Bone resorption by osteoclasts[J].Science,2000,289:1504-1508.
  • 3Kishimoto Y,Fukumoto S,Nishihara S,et al.Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis[J].Rheumatology,2004,43:1496-1503.
  • 4Quinn JM,Whitty GA,Byrne RJ,et al.The generation of highly enriched osteoclast-lineage cell populations[J].Bone,2002,30:164-170.
  • 5Wani MR,Fuller K,Kim NS,et al.Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors:synergistic activation of differentiation,cell spreading and fusion[J].Endocrinology,1999,140:1927-1935.
  • 6Wong BR,Rho J,Arron J,et al.TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cell[J].J Biol Chem,1997,272:25190-25196.
  • 7Yasuda H,Shima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL[J].Proc Natl Acad Sci,1998,95:3597-3602.
  • 8Yasuda H,Shima N,Nakagawa N,et al.A novel molecular mechanism modulating osteoclast differentiation and function[J].Bone,1999,25:109-133.
  • 9Li J,Sarosi I,Yan XQ,et al.RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism[J].Proc Natl Acad Sci USA,2000,97:1566-1571.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部